Clinical trial
POST-CABGDM: Empagliflozin in Perioperative CABG
NCT04523064
Study timeline
Study start (actual)2020-09-22Date precision: day
Registry last updated2024-06-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Coronary Artery Diseaseunresolved
Coronary Artery Bypass Surgeryunresolved
Acute Kidney Injuryunresolved
Interventions
Empagliflozin 25 MGDRUG · verified · RxNorm: empagliflozin 25 MG
Sponsors & collaborators
University of Sao Paulo General Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04523064 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.